INDIANAPOLIS, Sept. 14, 2016 (GLOBE NEWSWIRE) -- PTS Diagnostics, the US-based manufacturer of point-of-care biometric testing devices distributed across the globe, has been selected for an impressive sixth time to the prestigious Inc. 5000 list. For the 2016 Inc. 5000 list, PTS Diagnostics placed as the 3,772nd fastest growing private company in America based on three-year revenue growth of 81%. PTS Diagnostics is one of only 237 of the 5,000 companies listed this year to have been chosen for four consecutive years.
This designation puts PTS Diagnostics in the top 50 fastest growing companies in Indiana.
Founded in 1992, PTS Diagnostics was specially recognized by Inc. Magazine as a Six-Time Inc. 5000 honoree. The company earned its spot on the list with rankings in 2007, 2008, 2013, 2014, 2015 and now 2016.
“It is very much a pleasure to be included on this list once again. It speaks volumes for the hard work of our extremely talented team. PTS Diagnostics strives to bring innovative, point-of-care diagnostic products to healthcare professionals and consumers that are fast, easy to use and accurate,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “I am particularly proud of the fact that PTS Diagnostics ended its 24-year history as an independent private company with our fourth award in a row. Given our recent acquisition by Sinocare (a public company), we will cease to be eligible for this list next year.”
PTS Diagnostics’ products are manufactured in the United States and marketed globally. The company’s signature products include the CardioChek® family of lipid analyzers, A1CNow® systems and PTS Detect™ cotinine systems. In addition, the company is now actively marketing its PTS Connect™ solution, a connectivity and information management platform that increases healthcare professionals’ productivity, and offers population health management capabilities that engage participants to improve their health.
“Over the last three years, we have continued to grow not only our revenue base but also our product portfolio,” said Huffstodt. “We listened to the market and have developed products requested by our customers, such as the PTS Connect platform. This digital capture and secure results transfer system allows healthcare professionals best-in-class connectivity and information management solutions. When healthcare professionals combine our proven CardioChek analyzers and A1CNow+ systems with our PTS Connect platform, true population health management is possible.”
About PTS Diagnostics
PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, distributes and markets products for distribution in more than 135 countries around the world. PTS Diagnostics joins Trividia Health to become a member of Sinocare, a biosensor technology company that enables both medical professionals and individuals across the globe identify, monitor and diagnose chronic diseases at the point of care. For more information, visit www.ptsdiagnostics.com or contact Tom Wiser at 317-870-5610 or email@example.com.
About Inc. 5000
The Inc. 5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list of the nation's most successful private companies has become the hallmark of entrepreneurial success. The Inc. 5000 profiles are available on Inc.com.
Last updated on: 15/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.